Personalized medicine
Read more
Our mission is to pioneer innovative gene therapy solutions that transform the landscape of medicine. We strive to advance genetic research to develop safe and effective therapies for genetic disorders and complex diseases, empowering individuals and families through groundbreaking discoveries. We are committed to collaboration, ethical research practices, and the relentless pursuit of scientific excellence to improve the quality of life for patients worldwide.

Our vision is to shape the future of genomic medicine through pioneering research in molecular genetics, cell biology, genome editing, and biotechnology. We strive to develop innovative scientific platforms that will serve as the foundation for the next generation of personalized medicine, creating new opportunities for the treatment of rare genetic disorders, cancer, and other complex diseases.

We have established GeCure Solutions, a genetics research laboratory in Ukraine that brings together scientists, early-career researchers, and international partners to advance the future of genomic medicine. Our work focuses on developing innovative scientific platforms in molecular genetics, cell biology, genome editing, and biotechnology.
We are ambitious, highly qualified, and driven by a shared mission to develop next-generation personalized approaches for rare genetic disorders, cancer, and other complex diseases.

Personalized medicine, often referred to as precision medicine, marks a transformative approach within healthcare that tailors treatment and prevention strategies to the individual's unique characteristics, lifestyle, and ...
A report describing AS was published in 1965 by a British pediatrician Harry Angelman [1] . AS is a genetic disorder causing neurodevelopmental disease with a conserved and recognizable...
SBCS is a recently discovered genetic neurodevelopmental disorder, first described in 2018 by clinical researchers Lot Snijders Blok and Philippe Campeau. Individuals with this syndrome typically present with ...
SMA is a genetic disorder characterized by weakness and wasting (atrophy) in muscles used for movement (skeletal muscles). It is caused by a loss of specialized nerve cells, called motor neurons, in the spinal...
Generation of genetically modified mammalian cell lines (Knockout/Knock-in) using 4D-Nucleofection technology. From transfection with client-provided constructs to the complete development of custom research cell models for functional and preclinical studies. ...
Mutation in multiple genes were already described to be contributing to autism spectrum disorder. Although it is hard to make a defined prognosis, it is plausible that early detection of such mutations might allow to design a gene-therapy, tailored specifically for a given individual, and ...
The world’s most transformative medical breakthroughs begin with fundamental research. By supporting GeCure Solutions, you are investing not only in a research laboratory, but in scientific discoveries that have the potential to shape the future of medicine. Every donation and philanthropic contribution helps advance innovative genetic research, develop next-generation technologies, and build research platforms that may contribute to future breakthroughs with a lasting global impact on human health.
See more
Advances in molecular genetics, genome editing, and cell engineering are transforming the way complex
diseases are studied and future therapeutic strategies are developed. High-quality research models are essential for
understanding disease mechanisms, validating genetic targets, evaluating innovative technologies, and supporting
translational and preclinical research.
At GeCure Solutions, we integrate molecular genetics, genome editing, cell engineering, and advanced analytical technologies
to create reliable research platforms that accelerate scientific discovery and contribute to the development of
next-generation precision medicine.

